Marco Falasca. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Antineoplastic Agents/chemistryAntineoplastic Agents/metabolismAntineoplastic Agents/therapeutic useClinical Medicine/methodsClinical Medicine/trendsHumansNeoplasms/drug therapyNeoplasms/enzymologyPhosphatidylinositol 3-Kinases/metabolismPhosphoinositide-3 Kinase InhibitorsProtein Isoforms/antagonists & inhibitorsProtein Isoforms/metabolismProtein Kinase Inhibitors/chemistryProtein Kinase Inhibitors/metabolismProtein Kinase Inhibitors/therapeutic use
Substances: See more » Antineoplastic AgentsPhosphoinositide-3 Kinase InhibitorsProtein IsoformsProtein Kinase Inhibitors
Year: 2011 PMID: 21649576 DOI: 10.2174/092986711796011210
Source DB: PubMed Journal: Curr Med Chem ISSN: 0929-8673 Impact factor: 4.530